Carregant...

Detection of Early Response to Temozolomide Treatment in Brain Tumors Using Hyperpolarized (13)C MR Metabolic Imaging

PURPOSE: To demonstrate the feasibility of using DNP hyperpolarized [1-(13)C]-pyruvate to measure early response to temozolomide (TMZ) therapy using an orthotopic human glioblastoma xenograft model. MATERIALS AND METHODS: Twenty athymic rats with intracranial implantation of human glioblastoma cells...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Magn Reson Imaging
Autors principals: Park, Ilwoo, Bok, Robert, Ozawa, Tomoko, Phillips, Joanna J., James, C. David, Vigneron, Daniel B., Ronen, Sabrina M., Nelson, Sarah J.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4983457/
https://ncbi.nlm.nih.gov/pubmed/21590996
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.22563
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!